A Single-site, Single Masked, Prospective Comparison of Three Fluoroquinolone Topical Therapies (Besifloxacin 0.6% or Gatifloxacin 0.5% or Moxifloxacin 0.5%) in the Treatment of Infectious Corneal Ulcers.

Trial Profile

A Single-site, Single Masked, Prospective Comparison of Three Fluoroquinolone Topical Therapies (Besifloxacin 0.6% or Gatifloxacin 0.5% or Moxifloxacin 0.5%) in the Treatment of Infectious Corneal Ulcers.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 20 Aug 2015

At a glance

  • Drugs Besifloxacin (Primary) ; Gatifloxacin (Primary) ; Moxifloxacin (Primary)
  • Indications Bacterial infections; Corneal ulcer
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 Jun 2014 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
    • 02 Sep 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top